Adverse skin reactions to infliximab in the treatment of intraocular inflammation

Eye

Volumn 21, Issue 4, 2007, Pages 547-549

  Wegscheider, B J ^a   El Shabrawi, L ^a   Weger, M ^a   Ardjomand, N ^a   Hermann, J ^a   Aberer, E ^a   El Shabrawi, Y ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CEPHALOSPORIN; CYCLOSPORIN; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENICILLIN G;

ADULT; ARTICLE; CASE REPORT; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; IMPETIGO; PARANASAL SINUS DISEASE; PATIENT MONITORING; PENICILLIN RESISTANCE; PSORIASIS; PUSTULAR PSORIASIS; REMISSION; SKIN BIOPSY; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; UVEITIS;

EID: 34147182301     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702262     Document Type: Article

References (7)

1. Murphy CC, Greiner K, Plskova J, Duncan L, Frost NA, Forrester JV et al. Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis. Arch Ophthalmol 2004; 122(6): 845-851.
2. Rosenbaum JT, Smith JR. Anti-TNF therapy for eye involvement in spondyloarthropathy. Clin Exp Rheumatol 2002; 20(6 Suppl 28): S143-S145.
3. El-Shabrawi Y, Hermann J. Case series of selective anti-tumor necrosis factor alpha therapy using infliximab in patients with nonresponsive chronic HLA-B27-associated anterior uveitis: Comment on the articles by Brandt et al. Arthritis Rheum 2002; 46(10): 2821-2822; author reply 2-4.
4. Sfikakis PP, Iliopoulos A, Elezoglou A, Kittas C, Stratigos A. Psoriasis induced by anti-tumor necrosis factor therapy: A paradoxical adverse reaction. Arthritis Rheum 2005; 52(8): 2513-2518.
5. European, Agency, for, et al. http://www.emea.eu.int/pdfs/human/ press/pus/444500en.pdf.
6. Thurber M, Feasel A, Stroehlein J, Hymes SR. Pustular psoriasis induced by infliximab. J Drugs Dermatol 2004; 3(4): 439-440.
7. Verea MM, Del Pozo J, Yebra-Pimentel MT, Porta A, Fonseca E. Psoriasiform eruption induced by infliximab. Ann Pharmacother 2004; 38(1): 54-57.